Novartis Bioventures Ltd Insider Trading $ARPO Aerpio Pharmaceuticals, Inc.
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in Aerpio Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 4,188,508 shares
Latest Transaction: Apr 29 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in Aerpio Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 138,704 | 142,865 | 4,049,804 | 4.2 M to 4 M (-3.31 %) |
| Apr 29 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 563,096 | 579,989 | 4,188,508 | 4.8 M to 4.2 M (-11.85 %) |
| Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 16,403 | 16,895 | 4,751,604 | 4.8 M to 4.8 M (-0.34 %) |
| Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 27,554 | 28,381 | 4,768,007 | 4.8 M to 4.8 M (-0.57 %) |
| Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.97 | 7,100 | 6,887 | 4,795,561 | 4.8 M to 4.8 M (-0.15 %) |
| Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.99 | 28,794 | 28,506 | 4,802,661 | 4.8 M to 4.8 M (-0.60 %) |
| Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.04 | 30,908 | 32,144 | 4,831,455 | 4.9 M to 4.8 M (-0.64 %) |
| Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.08 | 57,438 | 62,033 | 4,862,363 | 4.9 M to 4.9 M (-1.17 %) |
| Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 140,230 | 152,851 | 4,919,801 | 5.1 M to 4.9 M (-2.77 %) |
| Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 32,991 | 33,321 | 5,060,031 | 5.1 M to 5.1 M (-0.65 %) |
| Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.02 | 27,525 | 28,076 | 5,093,022 | 5.1 M to 5.1 M (-0.54 %) |
| Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.02 | 24,661 | 25,154 | 5,120,547 | 5.1 M to 5.1 M (-0.48 %) |
| Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 47,900 | 48,379 | 5,145,208 | 5.2 M to 5.1 M (-0.92 %) |
| Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.96 | 58,033 | 55,712 | 5,193,108 | 5.3 M to 5.2 M (-1.11 %) |
| Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.97 | 51,754 | 50,201 | 5,251,141 | 5.3 M to 5.3 M (-0.98 %) |
| Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.95 | 116,909 | 111,064 | 5,302,895 | 5.4 M to 5.3 M (-2.16 %) |
| Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.91 | 63,100 | 57,421 | 5,419,804 | 5.5 M to 5.4 M (-1.15 %) |
| Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.94 | 88,835 | 83,505 | 5,482,904 | 5.6 M to 5.5 M (-1.59 %) |
| Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.99 | 50,749 | 50,242 | 5,571,739 | 5.6 M to 5.6 M (-0.90 %) |
| Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 177,762 | 179,540 | 5,622,488 | 5.8 M to 5.6 M (-3.06 %) |
| Aug 22 2018 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.90 | 5,300 | 20,670 | 5,800,250 | 5.8 M to 5.8 M (-0.09 %) |
| Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 5.00 | 560,000 | 2,800,000 | 5,805,550 | 5.2 M to 5.8 M (+10.68 %) |
Page: 1